We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 1,032 results
  1. Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade

    Background

    Mutations in BRCA1 or BRCA2 ( BRCA1/2 ) cause homologous recombination deficiency (HRD). Ovarian cancer (OvCa) patients harbouring HRD...

    Tingting Chen, Tong Yu, ... Yunyan Gu in British Journal of Cancer
    Article 26 May 2022
  2. Spatial decrease of synaptic density in amnestic mild cognitive impairment follows the tau build-up pattern

    Next to amyloid and tau, synaptic loss is a key pathological hallmark in Alzheimer’s disease, closely related to cognitive dysfunction and...

    Greet Vanderlinden, Jenny Ceccarini, ... Koen Van Laere in Molecular Psychiatry
    Article 06 July 2022
  3. Overview of Clinically Available Radiotracers for Imaging in Neurodegenerative Disorders

    Well-designed radiotracers for molecular imaging are powerful tools for the investigation of neurodegenerative disorders and for providing new means...
    Chapter 2023
  4. PET Quantification and Kinetic Analysis

    The use of radiopharmaceuticals and the imaging of their kinetics are key components to successful developments in PET. The state-of-the-art PET...
    Richard E. Carson, Mika Naganawa, Jean-Dominique Gallezot in Molecular Imaging of Neurodegenerative Disorders
    Chapter 2023
  5. Neuronal transcriptome, tau and synapse loss in Alzheimer’s knock-in mice require prion protein

    Background

    Progression of Alzheimer’s disease leads to synapse loss, neural network dysfunction and cognitive failure. Accumulation of protein...

    Austin Stoner, Li Fu, ... Stephen M. Strittmatter in Alzheimer's Research & Therapy
    Article Open access 15 November 2023
  6. The impact of brivaracetam on cognitive processes and anxiety in various experimental models

    Background

    Memory deficits and anxiety symptoms are undesirable effects that occur in epilepsy patients. They may be associated with the...

    Ewa Zwierzyńska, Bogusława Pietrzak in Pharmacological Reports
    Article Open access 05 January 2024
  7. Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with 18F-SynVesT-1 positron emission tomography imaging

    Purpose

    The loss of synaptic vesicle glycoprotein 2A (SV2A) is well established as the major correlate of epileptogenesis in focal cortical dysplasia...

    Yongxiang Tang, Jie Yu, ... Shuo Hu in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 03 January 2022
  8. Anti-convulsant Agents: Levetiracetam and Brivaracetam

    Levetiracetam (LEV) and brivaracetam (BRV) are pyrrolidone derivate compounds binding at the presynaptic SV2A receptor site and thus representing...
    Bernhard J. Steinhoff in NeuroPsychopharmacotherapy
    Reference work entry 2022
  9. The pharmacokinetics of [18F]UCB-H revisited in the healthy non-human primate brain

    Background

    Positron Emission Tomography (PET) imaging of the Synaptic Vesicle glycoprotein (SV) 2A is a new tool to quantify synaptic density. [ 18 F]UC...

    Sébastien Goutal, Martine Guillermier, ... Nadja Van Camp in EJNMMI Research
    Article Open access 07 April 2021
  10. Synaptic density affects clinical severity via network dysfunction in syndromes associated with frontotemporal lobar degeneration

    There is extensive synaptic loss from frontotemporal lobar degeneration, in preclinical models and human in vivo and post mortem studies....

    David J. Whiteside, Negin Holland, ... James B. Rowe in Nature Communications
    Article Open access 20 December 2023
  11. Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A)

    Purpose

    Synaptic abnormalities have been implicated in a variety of neuropsychiatric disorders, including epilepsy, Alzheimer’s disease, and...

    Songye Li, Zhengxin Cai, ... Yiyun Huang in European Journal of Nuclear Medicine and Molecular Imaging
    Article 07 June 2019
  12. Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [11C]UCB-J

    Background

    Attempts to associate amyloid-β (Aβ) pathogenesis with synaptic loss in Alzheimer’s disease (AD) have thus far been limited to small...

    Ryan S. O’Dell, Adam P. Mecca, ... Christopher H. van Dyck in Alzheimer's Research & Therapy
    Article Open access 05 January 2021
  13. Deep phenoty** towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort

    Background

    Major Depressive Disorder (MDD) is a heterogenous brain disorder, with potentially multiple psychosocial and biological disease mechanisms....

    Kristian Høj Reveles Jensen, Vibeke H. Dam, ... Martin Balslev Jørgensen in BMC Psychiatry
    Article Open access 09 March 2023
  14. Reduced C9orf72 function leads to defective synaptic vesicle release and neuromuscular dysfunction in zebrafish

    The most common genetic cause of amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia (FTD) is a hexanucleotide repeat expansion within...

    Zoé Butti, Yingzhou Edward Pan, ... Shunmoogum A. Patten in Communications Biology
    Article Open access 25 June 2021
  15. Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns

    Background

    The synaptic vesicle glycoprotein 2 (SV2) family is essential to the synaptic machinery involved in neurotransmission and vesicle...

    Emilia Lekholm, Mikaela M. Ceder, ... Robert Fredriksson in Cellular & Molecular Biology Letters
    Article Open access 15 February 2021
  16. Lower synaptic density is associated with psychiatric and cognitive alterations in obesity

    Obesity is a serious medical condition that often co-occurs with stress-related psychiatric disorders. It is recognized that the brain plays a key...

    Ruth H. Asch, Sophie E. Holmes, ... Irina Esterlis in Neuropsychopharmacology
    Article 22 July 2021
  17. Sapap3 deletion causes dynamic synaptic density abnormalities: a longitudinal [11C]UCB-J PET study in a model of obsessive–compulsive disorder-like behaviour

    Background

    Currently, the evidence on synaptic abnormalities in neuropsychiatric disorders—including obsessive–compulsive disorder (OCD)—is emerging....

    Dorien Glorie, Jeroen Verhaeghe, ... Steven Staelens in EJNMMI Research
    Article Open access 13 November 2020
  18. Cross-linking mass spectrometry uncovers protein interactions and functional assemblies in synaptic vesicle membranes

    Synaptic vesicles are storage organelles for neurotransmitters. They pass through a trafficking cycle and fuse with the pre-synaptic membrane when an...

    Sabine Wittig, Marcelo Ganzella, ... Carla Schmidt in Nature Communications
    Article Open access 08 February 2021
  19. Celf4 controls mRNA translation underlying synaptic development in the prenatal mammalian neocortex

    Abnormalities in neocortical and synaptic development are linked to neurodevelopmental disorders. However, the molecular and cellular mechanisms...

    Iva Salamon, Yongkyu Park, ... Mladen-Roko Rasin in Nature Communications
    Article Open access 27 September 2023
Did you find what you were looking for? Share feedback.